We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Sinovac’s COVID-19 Vaccine Approved by China for Emergency Use to Vaccinate High-Risk Groups

By HospiMedica International staff writers
Posted on 01 Sep 2020
Sinovac Biotech Ltd.’s (Beijing, China) COVID-19 vaccine candidate CoronaVac has been approved by China for emergency use to vaccinate high-risk groups such as medical staff, according to a report by Reuters.

Out of seven COVID-19 vaccines in the final trial stages globally, four are from China. Since July, China has been reportedly administering experimental COVID-19 vaccines to high-risk groups, and health authorities could expand the emergency use program to prevent any possible outbreaks during the autumn and winter. Recently, Chinese state media had reported that the government had approved two vaccine candidates in June for the emergency use program, but did not identify the vaccines. According to Reuters, China has officially provided little information about the COVID-19 vaccine candidates that have been given to high-risk people under its emergency use program or the number of people who have been vaccinated.

Image: CoronaVac (Photo courtesy of Sinovac Biotech Ltd.)
Image: CoronaVac (Photo courtesy of Sinovac Biotech Ltd.)

China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), also announced on social media that it had obtained emergency use approval for a COVID-19 vaccine candidate, but did not specify which of its two vaccine candidates that are currently in Phase 3 clinical trials.

Related links:
Sinovac Biotech Ltd.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Anterior Cervical Plate System
XTEND
New
Diagnostic Ultrasound System
MS1700C

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles